{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:14:36Z","timestamp":1760368476180},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T00:00:00Z","timestamp":1106697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00213-004-2130-1","type":"journal-article","created":{"date-parts":[[2005,1,30]],"date-time":"2005-01-30T11:06:08Z","timestamp":1107083168000},"page":"73-83","source":"Crossref","is-referenced-by-count":19,"title":["The four-plates test\u2013retest paradigm to discriminate anxiolytic effects"],"prefix":"10.1007","volume":"180","author":[{"given":"Nad\u00e8ge","family":"Ripoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Br\u00edd \u00c1ine","family":"Nic Dhonnchadha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"S\u00e9bille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bourin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Hasco\u00ebt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,26]]},"reference":[{"key":"2130_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(98)00046-3","volume":"20","author":"WM Abi-Saab","year":"1999","unstructured":"Abi-Saab WM, Bubser M, Roth RH, Deutch AY (1999) 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 20:92\u201396","journal-title":"Neuropsychopharmacology"},{"key":"2130_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-2999(93)90827-5","volume":"235","author":"N Andrews","year":"1993","unstructured":"Andrews N, File SE (1993) Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol 235:109\u2013112","journal-title":"Eur J Pharmacol"},{"key":"2130_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0028-3908(71)90074-8","volume":"10","author":"C Aron","year":"1971","unstructured":"Aron C, Simon P, Larousse C, Boissier JM (1971) Evaluation of a rapid technique detecting minor tranquilizers. Neuropharmacology 10:459\u2013469","journal-title":"Neuropharmacology"},{"key":"2130_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(02)00710-4","volume":"72","author":"LJ Bertoglio","year":"2002","unstructured":"Bertoglio LJ, Carobrez AP (2002a) Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol Biochem Behav 72:449\u2013455","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0091-3057(02)00958-9","volume":"73","author":"LJ Bertoglio","year":"2002","unstructured":"Bertoglio LJ, Carobrez AP (2002b) Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73:963\u2013969","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008877-200402000-00006","volume":"15","author":"LJ Bertoglio","year":"2004","unstructured":"Bertoglio LJ, Carobrez AP (2004) Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 15:45\u201354","journal-title":"Behav Pharmacol"},{"key":"2130_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0163-7258(90)90077-F","volume":"48","author":"G Biggio","year":"1990","unstructured":"Biggio G, Concas A, Corda MG, Giorgi O, Sanna E, Serra M (1990) GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 48:121\u2013142","journal-title":"Pharmacol Ther"},{"key":"2130_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(68)90170-2","volume":"4","author":"JR Boissier","year":"1968","unstructured":"Boissier JR, Simon P, Aron C (1968) A new method for rapid screening of minor tranquillizers in mice. Eur J Pharmacol 4:145\u2013151","journal-title":"Eur J Pharmacol"},{"key":"2130_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-002-1155-6","volume":"163","author":"F Borsini","year":"2002","unstructured":"Borsini F, Podhorna J, Marazziti D (2002) Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163:121\u2013141","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1460-9568.2003.02829.x","volume":"18","author":"A Bortolozzi","year":"2003","unstructured":"Bortolozzi A, Amargos-Bosch M, Adell A, Diaz-Mataix L, Serrats J, Pons S, Artigas F (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. Eur J Neurosci 18:1235\u20131246","journal-title":"Eur J Neurosci"},{"key":"2130_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0753-3322(96)85091-8","volume":"50","author":"M Bourin","year":"1996","unstructured":"Bourin M, Baker GB (1996) The future of antidepressants. Biomed Pharmacother 50:7\u201312","journal-title":"Biomed Pharmacother"},{"key":"2130_CR12","first-page":"72","volume":"17","author":"M Bourin","year":"1992","unstructured":"Bourin M, Hasco\u00ebt M, Mansouri B, Colombel MC, Bradwejn J (1992) Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci 17:72\u201377","journal-title":"J Psychiatry Neurosci"},{"key":"2130_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-4328(98)00046-1","volume":"98","author":"C Castellano","year":"1999","unstructured":"Castellano C, Cabib S, Puglisi-Allegra S, Gasbarri A, Sulli A, Pacitti C, Introini-Collison IB, McGaugh JL (1999) Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic cholinergic influences on memory storage. Behav Brain Res 98:17\u201326","journal-title":"Behav Brain Res"},{"key":"2130_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1015249706579","volume":"32","author":"MN Cook","year":"2002","unstructured":"Cook MN, Crounse M, Flaherty L (2002) Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure. Behav Genet 32:113\u2013118","journal-title":"Behav Genet"},{"key":"2130_CR15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0091-3057(02)00813-4","volume":"72","author":"SE Cruz-Morales","year":"2002","unstructured":"Cruz-Morales SE, Santos NR, Brandao ML (2002) One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behav 72:973\u2013978","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"NW Dunham","year":"1957","unstructured":"Dunham NW, Mya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208\u2013209","journal-title":"J Am Pharm Assoc"},{"key":"2130_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02244419","volume":"100","author":"SE File","year":"1990","unstructured":"File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100:281\u2013282","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0166-4328(93)90103-W","volume":"58","author":"SE File","year":"1993","unstructured":"File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199\u2013202","journal-title":"Behav Brain Res"},{"key":"2130_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","volume":"125","author":"SE File","year":"2001","unstructured":"File SE (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125:151\u2013157","journal-title":"Behav Brain Res"},{"key":"2130_CR20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF02246980","volume":"110","author":"SE File","year":"1993","unstructured":"File SE, Zangrossi H Jr (1993) \u201cOne-trial tolerance\u201d to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berl) 110:240\u2013244","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02245751","volume":"102","author":"SE File","year":"1990","unstructured":"File SE, Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of \u201cone-trial tolerance\u201d to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102:98\u2013101","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(92)90141-P","volume":"218","author":"SE File","year":"1992","unstructured":"File SE, Andrews N, Wu PY, Zharkovsky A, Zangrossi H Jr (1992) Modification of chlordiazepoxide\u2019s behavioural and neurochemical effects by handling and plus-maze experience. Eur J Pharmacol 218:9\u201314","journal-title":"Eur J Pharmacol"},{"key":"2130_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(81)90500-X","volume":"215","author":"JF Flood","year":"1981","unstructured":"Flood JF, Landry DW, Jarvik ME (1981) Cholinergic receptor interactions and their effects on long-term memory processing. Brain Res 215:177\u2013185","journal-title":"Brain Res"},{"key":"2130_CR24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0306-3623(96)00240-6","volume":"28","author":"R Gaggi","year":"1997","unstructured":"Gaggi R, Dall\u2019Olio R, Roncada P (1997) Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats. Gen Pharmacol 28:583\u2013587","journal-title":"Gen Pharmacol"},{"key":"2130_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","volume":"38","author":"A Gobert","year":"1999","unstructured":"Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38:315\u2013317","journal-title":"Neuropharmacology"},{"key":"2130_CR26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0091-3057(97)00093-2","volume":"58","author":"M Hasco\u00ebt","year":"1997","unstructured":"Hasco\u00ebt M, Bourin M, Couetoux du Tertre A (1997) Influence of prior experience on mice behavior using the four-plates test. Pharmacol Biochem Behav 58:1131\u20131138","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0091-3057(99)00191-4","volume":"65","author":"M Hasco\u00ebt","year":"2000","unstructured":"Hasco\u00ebt M, Bourin M, Colombel MC, Fiocco AJ, Baker GB (2000) Anxiolytic-like effects of antidepressants after acute administration in a four-plates test in mice. Pharmacol Biochem Behav 65:339\u2013344","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0091-3057(98)00008-2","volume":"60","author":"A Holmes","year":"1998","unstructured":"Holmes A, Rodgers RJ (1998) Responses of Swiss\u2013Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav 60:473\u2013488","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0149-7634(99)00030-5","volume":"23","author":"A Holmes","year":"1999","unstructured":"Holmes A, Rodgers RJ (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23:971\u2013980","journal-title":"Neurosci Biobehav Rev"},{"key":"2130_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(02)02874-1","volume":"459","author":"A Holmes","year":"2003","unstructured":"Holmes A, Rodgers RJ (2003) Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol 459:221\u2013230","journal-title":"Eur J Pharmacol"},{"key":"2130_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-4328(01)00184-X","volume":"122","author":"A Holmes","year":"2001","unstructured":"Holmes A, Iles JP, Mayell SJ, Rodgers RJ (2001) Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light\/dark exploration test. Behav Brain Res 122:159\u2013167","journal-title":"Behav Brain Res"},{"key":"2130_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(01)02596-3","volume":"907","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Dai J, Meltzer HY (2001) DOI, a 5-HT2A\/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res 907:151\u2013155","journal-title":"Brain Res"},{"key":"2130_CR33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","volume":"76","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O\u2019Laughlin IA, Meltzer HY (2001) 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521\u20131531","journal-title":"J Neurochem"},{"key":"2130_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00421535","volume":"37","author":"JJ Jacob","year":"1974","unstructured":"Jacob JJ, Tremblay EC, Colombel MC (1974) Enhancement of nociceptive reactions by naloxone in mice and rats. Psychopharmacologia 37:217\u2013223","journal-title":"Psychopharmacologia"},{"key":"2130_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0166-4328(00)00294-1","volume":"117","author":"MR Lamprea","year":"2000","unstructured":"Lamprea MR, Cardenas FP, Silveira R, Morato S, Walsh TJ (2000) Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav Brain Res 117:97\u2013105","journal-title":"Behav Brain Res"},{"key":"2130_CR36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(03)01422-5","volume":"464","author":"JF Liao","year":"2003","unstructured":"Liao JF, Hung WY, Chen CF (2003) Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur J Pharmacol 464:141\u2013146","journal-title":"Eur J Pharmacol"},{"key":"2130_CR37","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180\u2013185","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130051158","volume":"147","author":"IS McGregor","year":"1999","unstructured":"McGregor IS, Dielenberg RA (1999) Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats. Psychopharmacology (Berl) 147:174\u2013181","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1021800822997","volume":"22","author":"A Meneses","year":"2002","unstructured":"Meneses A (2002) Involvement of 5-HT(2A\/2B\/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? Cell Mol Neurobiol 22:675\u2013688","journal-title":"Cell Mol Neurobiol"},{"key":"2130_CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/nlme.1998.3866","volume":"71","author":"A Meneses","year":"1999","unstructured":"Meneses A, Hong E (1999) 5-HT1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol Learn Mem 71:207\u2013218","journal-title":"Neurobiol Learn Mem"},{"key":"2130_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","volume":"140","author":"BA Nic Dhonnchadha","year":"2003","unstructured":"Nic Dhonnchadha BA, Bourin M, Hascoet M (2003a) Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav Brain Res 140:203\u2013214","journal-title":"Behav Brain Res"},{"key":"2130_CR42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-4328(03)00179-7","volume":"147","author":"BA Nic Dhonnchadha","year":"2003","unstructured":"Nic Dhonnchadha BA, Hasco\u00ebt M, Jolliet P, Bourin M (2003b) Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res 147:175\u2013184","journal-title":"Behav Brain Res"},{"key":"2130_CR43","unstructured":"Nic Dhonnchadha BA, Ripoll N, Hasco\u00ebt M, Bourin M (in press) Implication of the 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the mouse four plates test"},{"key":"2130_CR44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.179.5.390","volume":"179","author":"DJ Nutt","year":"2001","unstructured":"Nutt DJ, Malizia AL (2001) New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179:390\u2013396","journal-title":"Br J Psychiatry"},{"key":"2130_CR45","first-page":"124","volume":"21","author":"SY Pan","year":"2000","unstructured":"Pan SY, Han YF (2000) Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine. Acta Pharmacol Sin 21:124\u2013130","journal-title":"Acta Pharmacol Sin"},{"key":"2130_CR46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(02)01893-9","volume":"447","author":"T Pattij","year":"2002","unstructured":"Pattij T, Groenink L, Oosting RS, van der Gugten J, Maes RA, Olivier B (2002) GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129\/Sv background. Eur J Pharmacol 447:67\u201374","journal-title":"Eur J Pharmacol"},{"key":"2130_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(00)03004-3","volume":"888","author":"EA Pehek","year":"2001","unstructured":"Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51\u201359","journal-title":"Brain Res"},{"key":"2130_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00443425","volume":"97","author":"PA Pierce","year":"1989","unstructured":"Pierce PA, Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118\u2013122","journal-title":"Psychopharmacology"},{"key":"2130_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0702751","volume":"128","author":"RHP Porter","year":"1999","unstructured":"Porter RHP, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF et al (1999) Functional characterisation of agonists at recombinant human 5-HT2A, 5-HT2B, and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13\u201320","journal-title":"Br J Pharmacol"},{"key":"2130_CR50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.lfs.2003.06.012","volume":"74","author":"RA Prado-Alcala","year":"2003","unstructured":"Prado-Alcala RA, Solana-Figueroa R, Galindo LE, Medina AC, Quirarte GL (2003) Blockade of striatal 5-HT2 receptors produces retrograde amnesia in rats. Life Sci 74:481\u2013488","journal-title":"Life Sci"},{"key":"2130_CR51","unstructured":"Ripoll N, Hasco\u00ebt M, Bourin M. The four-plate test: anxiolytic paradigm or analgesic one? submitted in Behav Brain Res"},{"key":"2130_CR52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02245704","volume":"113","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light\/dark tests of anxiety in mice. Psychopharmacology (Berl) 113:237\u2013242","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02253596","volume":"106","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106:102\u2013110","journal-title":"Psychopharmacology (Berl)"},{"key":"2130_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0091-3057(95)02156-6","volume":"54","author":"RJ Rodgers","year":"1996","unstructured":"Rodgers RJ, Johnson NJ, Cole JC, Dewar CV, Kidd GR, Kimpson PH (1996) Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol Biochem Behav 54:41\u201350","journal-title":"Pharmacol Biochem Behav"},{"key":"2130_CR55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","volume":"19","author":"C Sanchez","year":"1999","unstructured":"Sanchez C, Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467\u2013489","journal-title":"Cell Mol Neurobiol"},{"key":"2130_CR56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0306-3623(94)00148-G","volume":"26","author":"T Shimada","year":"1995","unstructured":"Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K, Watanabe H (1995) The modified light\/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26:205\u2013210","journal-title":"Gen Pharmacol"},{"key":"2130_CR57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0031-9384(90)90302-K","volume":"48","author":"HL Steenbergen","year":"1990","unstructured":"Steenbergen HL, Heinsbroek RP, Van Hest A, Van de Poll NE (1990) Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior. Physiol Behav 48:571\u2013576","journal-title":"Physiol Behav"},{"key":"2130_CR58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00176847","volume":"94","author":"M Titeler","year":"1988","unstructured":"Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213\u2013216","journal-title":"Psychopharmacology"},{"key":"2130_CR59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","volume":"27","author":"M Vaswani","year":"2003","unstructured":"Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuro-Psychopharmacol Biol Psychiatry 27:85\u2013102","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2130_CR60","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","volume":"22","author":"GV Williams","year":"2002","unstructured":"Williams GV, Rao SG, Goldman-Rakic PS (2002) The physiological role of 5-HT2A receptors in working memory. J Neurosci 22:2843\u20132854","journal-title":"J Neurosci"},{"key":"2130_CR61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0361-9230(92)90072-6","volume":"29","author":"H Zangrossi Jr","year":"1992","unstructured":"Zangrossi H Jr, File SE (1992) Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull 29:381\u2013388","journal-title":"Brain Res Bull"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2130-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:01:25Z","timestamp":1558627285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,26]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2130-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,26]]}}}